Is Fennec Pharmaceuticals (NASDAQ:FENC) A Risky Investment?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' When we think about how risky a company is, we always like

Simply Wall StMay 21 07:45 ET

Fennec Pharmaceuticals Is Maintained at Buy by Craig-Hallum

Fennec Pharmaceuticals Is Maintained at Buy by Craig-Hallum

Dow JonesMay 15 14:03 ET

Express News | Craig-Hallum Maintains Buy on Fennec Pharmaceuticals, Lowers Price Target to $17

BenzingaMay 15 13:53 ET

Fennec Pharmaceuticals: Temporary Setbacks With Strong Long-Term Outlook

TipRanksMay 15 08:25 ET

Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Fennec Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow JonesMay 15 07:20 ET

Fennec Pharmaceuticals Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/15/2024 90.11% HC Wainwright & Co. $18 → $15 Maintains Buy 04/04/2024 128.14% HC Wainwright & Co. $17 →

BenzingaMay 15 07:08 ET